Published in Cancer Weekly, September 8th, 1997
The company's proprietary state-of-the-art laser imaging technology, along with naturally-occurring fluorescent compounds and enhanced video application, allows imaging to detect the cancer either on the surface or within the colon wall in the early stages. The fluorescent dyes will aid in targeting the cancer cells.
Colon cancer is expected to develop in approximately 6...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.